MVP Health Care Prior Authorization Lookup
- MVP Health Care coverage criteria
- MVP Health Care contact directory
- All MVP Health Care policy updates
Latest MVP Health Care prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Duchenne Muscular Dystrophy Drug TherapyPrior authorization and coverage criteria for corticosteroid, exon-skipping, and gene therapy drugs used to treat Duchenne muscular dystrophy across MVP commercial, Medicaid, and applicable product lines.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-10-01Medicare Part B: LenmeldyThis policy governs prior authorization and coverage of Lenmeldy (atidarsagene autotemcel), an autologous hematopoietic stem cell-based gene therapy, for eligible Medicare Advantage members with specified forms of metachromatic leukodystrophy. It applies to providers requesting administration through the medical benefit.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-01Medicare Part B: Hemophilia Gene TherapyThis policy governs Medicare Part B coverage and prior authorization for the one-time gene therapies Roctavian and Hemgenix under the medical benefit. It applies to members with qualifying severe or moderately severe hemophilia who meet specified diagnostic, laboratory, clinical, and monitoring requirements.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-09-01Medicare Part B: Lyfgenia (Lovotibeglogene Autotemcel)This policy governs Medicare Part B coverage and prior authorization for Lyfgenia, a one-time gene therapy for members aged 12 years or older with sickle cell disease and recurrent vaso-occlusive crises. Coverage requires specified clinical documentation, treatment at a Qualified Treatment Center, and fulfillment of hematologic, organ-function, infection, and transplant-related criteria.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Medicare Part B: Enteral TherapyCoverage and prior authorization for enteral nutrition, modified solid foods, medical foods, and related enteral therapy for MVP Health Care Medicare members, including additional criteria for DSNP members in MAP plans.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Medicare Part B: SyfovreThis policy governs prior authorization and coverage of Syfovre (pegcetacoplan) administered under the Medicare Part B medical benefit. It applies to providers seeking coverage for members with geographic atrophy secondary to age-related macular degeneration.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Medicare Part B: Zopapogene imadenovec (Papzimeos)This policy governs Medicare Part B coverage and prior authorization requirements for Papzimeos (zopapogene imadenovec-drba) administered under the medical benefit. It applies to members seeking treatment for recurrent respiratory papillomatosis.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Teplizumab-mzwv (Tzield) Coverage CriteriaPrior authorization and medical-benefit coverage for intravenous teplizumab-mzwv (Tzield) for Medicare Part B members age 8 years and older with stage 2 type 1 diabetes who meet specified clinical, laboratory, dosing, and infection-related requirements.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01Medicare Part B: Lyme Disease/IV Antibiotic TreatmentThis policy governs Medicare Part B coverage and prior authorization requirements for intravenous antibiotics used to treat Lyme disease, including diagnostic confirmation, qualifying clinical manifestations, oral-therapy limitations, documentation, and treatment-duration requirements.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01Medicare Part B: Transthyretin-Mediated Amyloidosis TherapyThis Medicare Part B medical policy governs prior authorization and medical-necessity coverage for Onpattro (patisiran) and Amvuttra (vutrisiran) for eligible adults with transthyretin-mediated amyloidosis, including polyneuropathy and selected amyloid cardiomyopathy indications. It applies to providers treating MVP Health Care Medicare Advantage members under the medical benefit.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Medicare Part B: Dose Rounding for Systemic TherapyThis policy governs Optum Cancer Guidance Program dose rounding for selected Medicare Part B systemic cancer drugs, including dose-rounding criteria, prior authorization handling, and provider requirements when rounded doses are accepted or declined.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Medicare Part B: InfliximabThis policy governs prior authorization and medical-necessity criteria for infliximab and specified infliximab biosimilars billed under the Medicare Part B medical benefit, including initial and continued treatment for covered inflammatory and immune-mediated conditions.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Medicare Part B: SecukinumabThis policy governs prior authorization and medical-benefit coverage of provider-administered intravenous secukinumab (Cosentyx) for Medicare Part B members. It establishes specialist, indication-specific clinical criteria, documentation requirements, approval durations, and coverage exclusions.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2025-10-01Medicare Part B: Immunoglobulin TherapyThis policy governs prior authorization and Medicare Part B coverage for intravenous and subcutaneous immune globulin therapy, including specified billing codes, coverage criteria, authorization periods, vendor requirements, and continuation documentation. It primarily applies to Medicare members receiving therapy for primary immunodeficiency.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2025-04-01Herceptin (trastuzumab) medical benefit coverageDefines medical benefit coverage, prior authorization, and administration coding for Herceptin (trastuzumab) for MVP Health Care Medicaid members, primarily for cancer indications; applies to providers submitting medical benefit claims.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2025-04-01Perjeta (pertuzumab) medical benefit coverageDefines MVP Health Care Medicaid medical benefit coverage and prior authorization requirements for Perjeta (pertuzumab) for cancer diagnoses, including on-label and off-label use, and applicable administration and billing codes.All MVP Health Care updates
- Prior AuthReimbursement/Payment PolicyEff. 2024-02-27MVP Health Care Non-Covered Items (Durable Medical Equipment / HCPCS list)List of specific HCPCS/DME codes and whether they are covered across MVP Health Care lines of business (Commercial, ASO, Medicare, Medicaid); used to determine denials and prior-authorization requirements for durable medical equipment and related items.All MVP Health Care updates
- Prior AuthReimbursement/Payment PolicyEff. 2022-12-012022 MVP Health Care Payment Policies (Section excerpts)This document governs MVP Health Care's 2022 reimbursement and billing policies (selected sections in this excerpt) and affects providers submitting claims to MVP for covered services. It includes rules for after-hours codes, allergy testing and serum preparation, and evaluation & management services, plus notification/prior authorization information.All MVP Health Care updates
- Prior AuthReimbursement/Payment PolicyEff. 2022-09-012022 Payment Policies (Reimbursement and Billing Guidelines)This document compiles MVP Health Care's 2022 payment and reimbursement policy guidelines covering multiple service areas (e.g., after-hours, allergy testing, E&M), describing billing rules, reimbursement limits, and prior authorization/notification expectations for providers.All MVP Health Care updates
- Prior AuthReimbursement/Payment PolicyEff. 2022-06-01MVP Health Care 2022 Payment Policies (selected sections)This document provides MVP Health Care's reimbursement and billing policies for multiple service areas (e.g., After-Hours, Allergy Testing and Serum Preparation, Evaluation and Management), including coding rules, reimbursement limits, and prior authorization/notification guidance for providers submitting claims to MVP.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyEff. 2020-10-01Medicare Part B: TECELRA (afamitresgene autoleucel)Medicare Part B prior authorization and coverage for TECELRA, an autologous T-cell immunotherapy, for eligible MVP Health Care Medicare Advantage members with unresectable or metastatic synovial sarcoma.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyAdakveo (crizanlizumab-tmca) Coverage CriteriaThis policy governs medical-benefit coverage and prior authorization for Adakveo (crizanlizumab-tmca) for members with sickle cell disease who are age 16 years and older when medical-necessity criteria are met.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyApplied Behavior Analysis (ABA)This policy governs MVP Health Care coverage and authorization requirements for Applied Behavior Analysis (ABA), including diagnostic eligibility, clinical criteria, prior authorization documentation, and multidisciplinary care expectations. It applies to providers requesting ABA treatment authorization.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyCancer Guidance Program-Oncology Medication CoverageThis policy defines clinical criteria used by the Optum Cancer Guidance Program to review prior authorization requests for oncology medications covered under MVP's medical benefit, including chemotherapy, immunotherapy, targeted therapies, oral oncolytics, hematology-supportive agents, and other listed oncology drug therapies.All MVP Health Care updates
- Prior AuthClinical/Medical PolicyDonislecel (Lantidra) Pancreatic Islet Cellular TherapyThis medical policy governs coverage and prior authorization for donislecel-JUJN administered under the medical benefit for adults with type 1 diabetes mellitus and severe hypoglycemia-related complications. It applies to initial, second, and third infusions and defines required clinical documentation, exclusions, and lifetime infusion limits.All MVP Health Care updates
Tool Description
Search MVP Health Careprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.